AMFV

4th Symposium,ISoP Latin American Chapter

Hervé Le Louët, FrancePresident CIOMS, Member of PRAC (EMA)Brian Edwards, UKISoP Chapters CoordinatorElki Sollenbring, Sweden UMC, Education and Consulting TeamAnthony Wong, Brazil Poison Control Centre (CEATOX)Liliana Vargas, MexicoNational Autonomous University of Mexico (UNAM)Luis Alesso, ArgentinaISoP Latin American Chapter PresidentRaquel Herrera Comoglio, ArgentinaISoP Latin American Chapter CoordinatorSten Olsson, Sweden ISoP President

SYMPOSIUM FACULTY

AMFV

FOURTH SYMPOSIUM,ISOP LATIN AMERICAN CHAPTERDECEMBER 5-6, 2017

AUDITORIUM HOSPITAL ANGELES ACOXPA430, CALZ ACOXPA 430, EX-HACIENDA COAPA,14308 CIUDAD DE MÉXICO, CDMX

ISoP, Latin American and Mexican Chapter welcome

Overview of the global pharmacovigilance situation and current trends

Developing a positive reporting culturePharmacovigilance in Latin America: Time to speak out

4th Symposium, ISoP Latin American ChapterAGENDA DEC 5IN COLLABORATION WITH THE ISOP MEXICAN CHAPTER

4th Symposium, ISoP Latin American ChapterAGENDA DEC 6IN COLLABORATION WITH THE ISOP MEXICAN CHAPTER

09:00-09:15

09:15-10:00

10:00-10:30

10:30-11:00

Time Section Talk Speaker Time Section Talk SpeakerOpening Sten Olsson

Luis AlessoEverardo Vázquez

Interactive Discussion Panel

Panel Chairman: Luis Alesso

09:00-10:30 Pharmacovigilancefrom the patientstandpoint

Carlos CastroBeatriz CapdevielleAlma RoblesRocío Alatorre Eden-WynterRosana Angélica RamirezSten Olsson

10:45-12:00 Pharmacovigilanceof Biotherapeuticmedicines

Present regulation in biologic therapies

13:00-14:45 Clinical Studies inPharmacovigilance

Brian Edwards

Medication errors: EU Regulatory initiatives on risk minimization

15:00-15:30

15:30-16:00

16:00-16:30

Pharmacovigilanceand Public Health

Hervé Le Louët

16:30-17:00 Closing Remarks Luis AlessoEverardo VázquezSten Olsson

Antibiotic resistance as a pharmacovigilance target

Carlos Amábile-Cuevas

Patient Safety in Public Health Programs

Sten Olsson

Naming, extrapolation, indication Abdiel Esquivel

Interchangeability and pharmacovigilance

Daniel Xibillé Friedman

Pharmacovigilance and Biologics Lucila Isabel Castro-Pastrana

The new Mexican regulation and its impact

11:30-13:00 Strategies forincreasing thequantity andquality ofspontaneousreporting

Rocío Alatorre Eden-Wynter

Pharmacovigilance: Impact of new regulation in México

Quality of the ADR reports – Sao Paulo, Brazil

Josue Bautista Arteaga

Adalton Ribeiro

Sten Olsson

Elki Sollenbring

Luis Alesso

Coffee Break

Coffee Break

Coffee Break

Lunch

CIOMS Perspective:Risk Management Plans

15:30-16:00

16:00-16:30

16:30-17:00

Risk managementPlans

Hervé Le Louët

RMP: Trials and tribulations…lessons to be learned

Brian Edwards

RMP: A collaborative perspective Gloria Giraldo

Coffee Break

Teaching Pharmacovigliance to Medical, Nursing and Pharmacy Students

14:00-15:10 TeachingPharmacovigilancein Universities

Anthony Wong

Carlos Calderon Ospina

Liliana Vargas

Marcelo Luis Ponte

Experience of Universidad del Rosario, Colombia

Learnings from National Autonomous University,Teaching Pharmacovigilance in Buenos Aires

Lunch Non insulin glucose-lowering agents and cardiovascular outcomes in Type 2 DM

Jorge Machado-AlbaExperiences from Colombia

Oscar Rosas-CarrascoElderly people safety

Raquel Herrera Comoglio